Compare LEXX & IHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LEXX | IHT |
|---|---|---|
| Founded | 2004 | 1971 |
| Country | Canada | United States |
| Employees | 7 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.5M | 13.3M |
| IPO Year | N/A | 1995 |
| Metric | LEXX | IHT |
|---|---|---|
| Price | $0.61 | $1.41 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.50 | N/A |
| AVG Volume (30 Days) | ★ 84.9K | 12.6K |
| Earning Date | 04-13-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 1.77% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $7,600,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $601.47 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1.33 |
| 52 Week Low | $0.46 | $0.95 |
| 52 Week High | $1.55 | $4.24 |
| Indicator | LEXX | IHT |
|---|---|---|
| Relative Strength Index (RSI) | 41.16 | 53.56 |
| Support Level | $0.57 | $1.37 |
| Resistance Level | $0.69 | $1.51 |
| Average True Range (ATR) | 0.05 | 0.08 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 10.63 | 19.05 |
Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.
InnSuites Hospitality Trust is a real estate investment trust. It is engaged in the ownership and operation of hotel properties. It owns and operates hotels, provides management services for hotels, and also provides trademark license services. The Trust is also involved in various operations incidental to the operation of hotels, such as the operation of restaurants, meeting/banquet room rentals, and the operation of a reservation system. It has one reportable segment Hotel Operations & Hotel Management Services.